Sodium butyrate (NaB) inhibits proliferation, stimulates apoptosis, and promotes differentiation of human colon cancer cells along the absorptive phenotype. In vitro, butyrate induces a switch from cells with a secretory to an absorptive phenotype. Here, we report that NaB specifically represses the expression of the MUC2 gene, a differentiation marker of the secretory goblet cell lineage, in forskolin-and 12-O-tetradecanoylphorbol 13-acetateinduced HT29 cells, and Cl.16E cells, a clonal derivative of HT29 cells that spontaneously differentiates into goblet cells. Thus, NaB repression is independent of the nature of the stimulus that triggers MUC2 expression. Further, repression was independent of new protein synthesis. Our results suggest that inhibition of MUC2 is linked to the ability of butyrate to repress histone deacetylase activity, since trichostatin A, another inhibitor of histone deacetylases, also inhibited MUC2 expression in induced HT29 cells. Finally, we demonstrate that the NaB effect is specific for this marker of the secretory cell lineage, since carcinoembryonic antigen, which is expressed in both the secretory and absorptive cells, is induced by NaB. Thus, the NaB repression of a definitive function of the secretory cell lineage is a further mechanism, in addition to the effects on proliferation and apoptotic pathways, through which butyrate can regulate intestinal homeostasis.
Introduction
Homeostasis and normal function of the intestinal mucosa involves not only a balance between stem cell proliferation in the lower two-thirds of the crypt and cell loss by extrusion into the lumen, which may or may not be accompanied by apoptosis, but also the maintenance of a balance among the multiple cell lineages in the mucosa. In this respect, we have recently reported that alteration of goblet cell function via inactivation of the Muc2 gene, which encodes the major intestinal mucin and is specifically expressed in goblet cells (Allen et al., 1998) , leads to the development of intestinal tumors (Velcich et al., 2002) . Thus, understanding the mechanisms that regulate the balance among different cell lineages in the intestine is critical to understanding intestinal tumor development. Balance among different cell lineages is accomplished by the interaction of programmed pathways of cell maturation, cell-cell and cell-matrix interactions, with additional signals generated by the lumenal contents. In the latter category are short-chain fatty acids (SCFAs), especially butyrate, which are generated by microbial fermentation of dietary fiber (Hill, 1995) , and which serve as the principal energy source for colonic epithelial cells (Rowe and Bayless 1992; Scheppach, 1994) . Butyrate has been shown to be a physiological regulator of cell maturation in the intestinal tract, modulating the pathways of proliferation, differentiation, and apoptosis (Heerdt et al., 1994; Augenlicht et al., 1999) .
Some effects of butyrate on differentiation have been well studied. In transformed colonic epithelial cells in vitro, butyrate induces markers that characterize the absorptive cell lineage. Interestingly, in HT29 and T84 cells sodium butyrate (NaB) induces a switch from cells displaying secretory characteristics to an absorptive phenotype, as demonstrated by the loss of chloride secretion and acquisition of absorptive functions (Matthews et al., 1998) . Furthermore, expression of intestinal trefoil factor (ITF/TFF3), a gene that is also, although not uniquely, expressed in goblet cells was decreased in response to NaB treatment in several colon cancer cell lines (Tran et al., 1998) . Perhaps, related to this, recognizable goblet cells, the secretory cell lineage responsible for the synthesis and secretion of mucus in the intestine, are under-represented towards the top of the colonic crypt where cells may be exposed to the highest concentration of SCFAs (Paulus et al., 1993) . We, therefore, addressed the question of whether butyrate, which stimulates absorptive markers while repressing secretory markers in enterocytes, plays a role in repressing MUC2 expression, the gene that encodes the major form of secreted colonic mucin. This was investigated in two cell systems in which different stimuli, forskolin (F) or 12-O-tetradecanoylphorbol 13-acetate (TPA) in HT29 cells, and cell-cell interaction in CL.16E cells, trigger the expression of the MUC2 gene.
The data demonstrate that butyrate does indeed specifically suppress expression of MUC2 and that this is likely because of its role as an inhibitor of histone deacetylase (HDAC) activity.
Thus, butyrate, a SCFA that is a physiological modulator of cell maturation in the colon (Heerdt et al., 1994; Augenlicht et al., 1999) , can regulate intestinal homeostasis not only by affecting the ratio between proliferation and apoptosis, but also by modulating the balance and localization of different cell lineages.
Results

NaB inhibits MUC2 gene expression
We previously reported that in HT29 cells F and TPA treatment induced MUC2 mRNA and protein, by protein kinase A and C (PKA and PKC) dependent mechanisms, respectively (Velcich and Augenlicht, 1993) . As shown in Figure 1a , in F-treated HT29 cells MUC2 mRNA began to accumulate 4 h after treatment. As we and others have reported, MUC2 mRNA shows size variability when detected on Northern blot; this is a well-known characteristic of MUC2 and other mucin mRNAs most likely attributable to partial mRNA degradation because of the large size of these mRNAs (Debailleul et al., 1998) . We reported earlier that butyrate is not an effective inducer of MUC2 expression (Velcich and Augenlicht, 1993) . Moreover, the simultaneous treatment of cells with F and NaB completely eliminated the F-induced expression (Figure 1a ). Butyrate also repressed MUC2 expression in HT29 cells induced by TPA (not shown). The level of MUC2 repression was a function of NaB concentration (data not shown), and we routinely used a concentration of 5 mm that had a minimal effect on cell viability (data not shown). To ascertain whether NaB blocked MUC2 induction independently of new protein synthesis, the level of MUC2 mRNA was analysed in F-induced cells in the presence of the protein synthesis inhibitors anisomycin (aniso) and cycloheximide (cxe), as we have previously shown that F, but not TPA, induction of MUC2 was independent of de novo protein synthesis. As shown in Figure 1b pretreatment with the inhibitors did not alter the kinetics of induction of MUC2 mRNA in F-treated cells, as we previously reported, nor did it affect the ability of NaB to block this induction, demonstrating that de novo protein synthesis was not required for the repression of MUC2 expression by butyrate.
To investigate whether the inhibitory effects of NaB were specific for the F-and TPA-activated pathways of MUC2 induction in HT29 cells, or whether NaB could repress MUC2 expression independently of the inducing stimulus, we ascertained whether NaB could block MUC2 mRNA accumulation in Cl.16E cells. Cl.16E cells, a clonal derivative of HT29 cells, differentiate into goblet cells upon contact inhibition of growth. This lineage-specific differentiation is characterized by the expression of the MUC2 gene, and subsequent mucin synthesis, glycosylation and secretion, accompanied by cell polarization, development of tight junctions, and loss of tumorigenicity (Augeron and Laboisse, 1984; Augenlicht et al., 1987; Laboisse 1989) . Thus, Cl.16E cells recapitulate the in vivo differentiation of the goblet cell lineage. In Figure 2a , the kinetics of induction of MUC2 mRNA in Cl.16E cells, as a function of time after plating, showed that MUC2 mRNA began to accumulate at day 7 (d7) and reached a plateau at day Figure 1 MUC2 mRNA accumulation is inhibited by NaB in HT29 cells. (a) HT29 cells were treated with forskolin (F) alone or in the presence of NaB for the indicated time periods. Total RNA was isolated and analysed by Northern blot for MUC2 mRNA levels. The level of GAPDH mRNA was also determined to control for equal RNA loading and RNA integrity. (b) HT29 cells were pretreated with anisomycin and cyclohexamide for 30 min prior to the addition of the inducers; total RNA was isolated and analysed as described in (a) 15, in agreement with our previous data (Jarry et al., 1994; Velcich et al., 1995) . At day 15 after subculture, when MUC2 expression had reached maximum level, cells were treated over a period of 72 h with NaB, and the levels of MUC2 mRNA determined. As shown in Figure 2b , there was a marked reduction of MUC2 mRNA as a function of time after butyrate treatment. By 24 h post-treatment MUC2 mRNA level was approximately 50% that of control cells, and further decreased by 48 h. This gradual decline was in agreement with the established long half-life for this mRNA (Debailleul et al., 1998) .
The activation of the MUC2 gene in Cl.16E cells results in the accumulation of MUC2 apomucin as well as mRNA. Therefore, to determine whether the block to MUC2 mRNA accumulation by NaB resulted in inhibition of apomucin production, we used Western blot analysis with a monoclonal antibody, M53, that we generated against a fusion protein encompassing three complete tandem repeats of the MUC2 apomucin (O'Boyle and Velcich, unpublished) . As shown in Figure 2c , in extracts from untreated, differentiated (15 day postplating) Cl.16E cells, the level of MUC2 protein was constant over a period of 24-48 h; in contrast, the level of MUC2 protein was progressively reduced in extracts from cells treated with NaB for 24 or 48 h.
NaB inhibitory activity is reversible and specific
We next investigated whether the inhibition of MUC2 expression was dependent upon the continuous presence of butyrate. At 15 days postplating, Cl.16E cells were treated with NaB for 6 days, the cells were washed to remove the SCFA and then maintained in normal (NaBfree) medium. Figure 3a shows that in cells exposed to NaB for 6 days, the level of MUC2 mRNA was greatly reduced. However, upon NaB removal, MUC2 expression gradually recovered over a 3-day period. By 72 h following NaB withdrawal, MUC2 mRNA level was comparable to the level in d9 cells never exposed to butyrate. Thus, the inhibitory effect of NaB was transient, and did not involve irreversible epigenetic changes of the MUC2 locus.
It is unlikely that the block of MUC2 expression by NaB was because of a general suppression of gene expression, since NaB is known to activate the expression of a number of markers of differentiation along the absorptive cell lineage. Accordingly, we demonstrated that although MUC2 expression was inhibited by NaB in Cl.16E cultures at 15 days postplating, the expression of carcinoembryonic antigen (CEA), a gene expressed in both the goblet and enterocyte lineage (Nap et al., 1988; Chang et al., 1994) , was in fact elevated ( Figure 3b ). This increase of CEA expression returned to control levels upon NaB removal (Figure 3b ). Thus, butyrate specifically inhibited MUC2 expression, and our results also demonstrated that the activity of NaB, whether stimulatory or inhibitory, was transient and depended upon the continuous presence of the SCFA.
NaB treatment does not alter MUC2 mRNA stability
To elucidate the mechanisms of MUC2 repression by NaB, we investigated whether MUC2 mRNA stability was affected by NaB. RNA synthesis in confluent Cl.16E cells was blocked by treatment with actinomycinD in the presence or absence of NaB. As shown in Figure 4a , the rate of disappearance of MUC2 mRNA was not appreciably different in cultures maintained in the presence or absence of NaB indicating that butyrate did not alter the rate of degradation of MUC2 mRNA. Cl.16E cells, 15 days after plating, were maintained in the absence (c) or presence of NaB. At the indicated time points total RNA was isolated and analysed for MUC2 mRNA levels. Northern blot analysis was performed as described in (c). The level of MUC2 apomucin was analysed in untreated (c), or NaB-treated cells. At the indicated time points, cell extracts were prepared and analysed by Western blot using a monoclonal antibody (M53) generated against a fusion protein corresponding to three complete twenty three amino acid tandem repeat (O'Boyle and Velcich, unpublished), as described in Materials and methods. Also shown (M) is the position and weight of markers, in kilodaltons
As a control for the efficacy of actinomycinD treatment, we analysed the level of c-MYC mRNA, a short-lived mRNA with a half-life of approximately 20 min. As expected, c-MYC mRNA was rapidly eliminated either in the presence or absence of NaB (Figure 4b ).
Induction-specific inhibitory effects of NaB and trichostatin A (TSA) on MUC2 regulation
An important mechanism by which NaB modulates gene expression is through its role as an inhibitor of HDAC activity (Sealy and Chalkley, 1978; Csordas, 1990; Bradbury 1992) . Thus, to investigate whether the inhibition of HDAC played a role in the repression of MUC2 expression, we asked whether TSA, an HDAC inhibitor structurally unrelated to NaB (Yoshida et al., 1990) , could also inhibit MUC2 expression in both HT29 and Cl.16E cells. Figure 5a shows that in F-or TPA-treated HT29 cells induction of MUC2 mRNA was reduced by more than 90% by cotreatment with TSA. The magnitude of the repression was similar to the inhibition seen with NaB. However, in differentiated cultures of Cl.16E cells TSA failed to repress MUC2 expression, and also did not upregulate CEA mRNA levels, contrary to the effects of NaB treatment (Figure 5b) . Differentiated Cl.16E cells are contact inhibited, and thus not in the cell cycle, while HT29 cells are. Thus, it was possible that the different responses of HT29 and Cl.16E cells to TSA depended upon the state of proliferation of the cells. However, by investigating whether TSA could inhibit MUC2 expression in growing cultures of Cl.16E cells (3 days postplating), a time during which MUC2 expression is first detected, we determined that accumulation of MUC2 mRNA was again unaffected by TSA treatment, while it was repressed by NaB (data not shown). Thus, the difference in growth state of HT29 and Cl.16E cells cannot explain the inhibition of MUC2 expression by TSA in the former, but not in the latter, cells.
The different kinetics of HDAC inhibition by NaB and TSA account for their apparent differential ability to inhibit MUC2 expression in Cl.16E cells
In differentiated Cl.16E cells, the MUC2 gene remains constitutively expressed once the gene is activated in Figure 3 The inhibitory (and stimulatory) effects of NaB are transient. Cl.16E cells, 15 day post plating, were treated in the presence or absence (c) of NaB for 6 days. Cultures were then washed twice with PBS and incubated in normal (NaB-free) medium. At the indicated time points total RNA was isolated and analysed by Northern blot. Levels of MUC2 (a) and CEA (b) mRNAs, relative to GAPDH mRNA level, were calculated from a representative experiment and the values plotted as a function of time response to the differentiation stimulus, (i.e. contact inhibition), and the effects of the inhibitory agents were tested over a period of 72 h. In contrast, in F-and TPAstimulated HT29 cells, MUC2 gene expression is induced transiently, and the effects of the inhibitors were monitored over a shorter, 8 h, period of time. To test whether the difference in TSA effects in HT29 and Cl.16E cells were because of the different kinetics of MUC2 induction and HDAC inhibition in the two cell systems, we investigated the ability of TSA to block MUC2 expression in HT29 cells over longer periods of time. As shown in Figure 6a , F induction of MUC2 expression peaked at 8 h, and it was reduced by 50% at 26 h. In F-induced cells treated simultaneously with TSA, MUC2 mRNA was undetectable up to 8 h, but accumulated at levels similar to F-treated cells by 26 h, suggesting that TSA inhibitory effects were transient. This is in contrast to the repressive effects of NaB, which persisted through the 26 h time course of the experiment. We have previously shown that the kinetics of elevation of histone H4 acetylation in SW620 cells by NaB and TSA are distinct (Mariadason et al., 2000) . Thus, we analysed the kinetics of histone H4 acetylation in control and F-induced HT29 cells in the presence or absence of NaB and TSA, as a measure of HDAC inhibition. Figure 6b shows that the levels of acetylated histone H4 were very low in control HT29 cells and remained low during F induction. However, the acetylated form of histone H4 was detectable in NaBtreated cells 2 h after treatment, and steadily accumulated up to 24 h, the last time point considered. In TSA-treated cells acetylation of histone H4 followed different kinetics. Acetylated histone H4 was induced after 2 h treatment, declined by 50% at 4 h, and was undetectable by 8 h. Thus, these data demonstrated that there is a direct correspondence between the differential ability of TSA and NaB to inhibit MUC2 gene expression and the different kinetics of inhibition of HDAC activity, as reflected in the accumulation of acetylated histone H4. Similarly, in differentiated Cl.16E cells NaB treatment induced a steady-state accumulation of acetylated histone H4 beginning 2 h post-treatment and remaining constant up to 24 h. In contrast, but in agreement with the result obtained in HT29 cells, TSA treatment induced a transient accumulation of acetylated H4 histone at 2 h, followed by a return to basal level (Figure 6c ). The transient action of TSA was not because of the establishment of a refractory status of Cl16.E cells, but to the unstable nature of the compound, as demonstrated by the fact that after 2, 6 or 22 h initial exposure of Cl.16E cells to TSA the addition of fresh TSA for additional 2 h resulted in the accumulation of acetylated H4 histone (Figure 6c , compare 4 h with 2 h þ 2 h etc). In agree- In all, 15-day-old cultures of Cl.16E cells were treated with TSA or NaB for the indicated times. Total RNA was isolated and analysed by Northern blot for MUC2 and CEA mRNA levels. Also shown is the quantification of MUC2 mRNA levels relative to GAPDH levels Repression of MUC2 gene by butyrate L Augenlicht et al ment, we further confirmed that MUC2 repression by NaB was linked to the sustained inhibition of HDAC activity by investigating the effects of SAHA, an HDAC inhibitor more stable than TSA, in F-induced HT29 cells as well as growing and confluent Cl16E cells. In all the experimental conditions tested, SAHA repressed MUC2 expression with the same potency as NaB (data not shown).
Inhibition of MAP kinase does not block NaB-mediated downregulation of MUC2 in Cl.16E cells
The Erk signaling pathway has been implicated in the regulation of the MUC2 gene in several cell lines (Taupin and Podolsky, 1999; Lee et al., 2002; Perrais et al., 2002) . In addition, it has been reported that the transcriptional activity modulated by HDAC inhibitors is mediated by the activation of both kinases and phosphatases (Cuisset et al., 1997 (Cuisset et al., , 1998 Espinos et al., 1999) . Specifically, it was shown by Espinos et al. (1999) that the mitogen-activated protein kinase kinase-1 (MEK-1)-specific inhibitor PD98059 blocked NaBinduced activation of the H1 0 gene (Espinos et al., 1999) . Therefore, to ascertain whether MEK-1 activation played a role in repressing MUC2 expression, we tested the ability of PD98059 to inhibit NaB repression of MUC2 in Cl.16E cells. Growing cultures (3 days postplating) of Cl.16E cells were treated for 30 min with PD98059 prior to the addition of NaB, and total RNA was isolated 48 h later. As shown in Figure 7a pretreatment of Cl.16E cells with PD98059 did not block the inhibitor effect of NaB, while treatment with PD98059 alone induced MUC2 mRNA levels, consistent with the results obtained in HT29-N2 cells (Taupin and Podolsky 1999). Thus, inhibition of the MAP kinase pathway is not involved in the repression of MUC2 by NaB. Further, PD98059 could not relieve the repressive effect of butyrate treatment in F-induced HT29 cells. Finally, in contrast to the inducing effects on MUC2 in Cl.16E cells, in HT29 cells PD98059 not only did not upregulate MUC2 expression, but it repressed MUC2 mRNA accumulation in F-induced HT29 cells (Figure 7b ). These data established that the mechanisms regulating MUC2 expression are distinct in HT29 induced cells and in Cl.16E cells. However, despite this divergence, the pathways that result in MUC2 expression in the two systems are equally sensitive to the repressive effects of butyrate.
NaB can modulate Cl.16E cell differentiation program
NaB is a well-established differentiation agent, which induces aspects of the differentiation program of the absorptive cell lineage in a number of intestinal cell systems. One of the most commonly investigated markers for enterocyte-specific differentiation is alkaline phosphatase, which, in fact, is efficiently induced by NaB in HT29 cells (Gum et al., 1987) . Therefore, we investigated whether besides repressing the development of the secretory cell phenotype, NaB could redirect the differentiation program of Cl.16E cells, which are derived from HT29 cells, and induce markers of the absorptive cell lineage in this clone. Figure 8 shows that exposure of growing cultures of Cl.16E cells to NaB induces low levels of alkaline phosphatase mRNA, as determined by quantitative real time PCR analysis. However, in fully differentiated cultures of Cl.16E cells NaB could not induce alkaline phosphatase mRNA, despite the fact that these cultures are responsive to NaB as demonstrated by the downregulation of MUC2 expression. These data were confirmed by Northern blot analysis (data not shown). Thus, since the Cl.16E cells are fully committed to the goblet cell lineage, NaB can modulate pathways involved in this lineage, but cannot redirect the cells along the absorptive cell lineage.
Discussion
In human adenocarcinoma cell lines in vitro, NaB causes a cell cycle arrest, accompanied by induction of markers The kinetics of H4 acetylation in Finduced HT29 cells, treated with TSA or NaB for the indicated time periods, were determined by Western blot analysis using an antiacetylated H4-specific antibody. H1 level in the extracts is also shown as control for equal loading and protein transfer. (c) Kinetics of H4 acetylations were compared in differentiated Cl.16E treated with NaB and TSA at the indicated time points, as described in (b) To test for refractoriness to TSA treatment Cl.16E cells were treated with a single dose of TSA followed by the addition of fresh TSA at 2, 6 and 22 h after the initial exposure. Cells were then harvested 2 h later Repression of MUC2 gene by butyrate L Augenlicht et al of absorptive cell differentiation and apoptosis. Here, we demonstrate that NaB blocks MUC2 gene expression and apomucin production in F-and TPA-induced HT29 cells as well as in the Cl.16E cell line, the latter being a clonal derivative of HT29 cells which spontaneously differentiates in culture into goblet cells (Augeron and Laboisse, 1984) . Thus, inhibition of MUC2 gene expression by NaB is independent of the nature of the stimulus that triggers MUC2 expression. The ability of NaB to repress MUC2 independently of the stimulus that triggers MUC2 expression was further documented in cultures of Cl19A cells, another clonal derivative of HT29 cells, that differentiate as ion transporter cells at confluence. Both growing (undifferentiated) and confluent (differentiated) Cl19A cells upregulated MUC2 expression in response to F and TPA treatment, and such induction was blocked by cotreatment with NaB (data not shown). The inhibitory effect of NaB over-rides F-induced MUC2 expression in treated HT29 cells and Cl19A cells, since there is no accumulation of MUC2 mRNA in cells treated simultaneously with the two agents, and does not depend on new protein synthesis. Furthermore, we demonstrated that NaB repression of MUC2 was not because of alteration of its mRNA stability. However, several experiments for analysing the rate of MUC2 gene transcription in control and NaB-treated HT29 or Cl.16E cells did not give consistent results, most likely because of the low activity of the MUC2 promoter (Velcich et al., 1997) .
Inhibition of HDAC activity as a mechanism of NaB inhibition of MUC2 gene expression NaB has long been known to modulate gene expression, and, since it is a well-established inhibitor of histone deacetylases, a likely mechanism of this effect is the alteration by NaB of chromatin conformation through hyperacetylation of histones (Csordas, 1990 (Csordas, , 1995  Figure 7 NaB inhibition of MUC2 expression is not mediated by the MAP kinase pathway. Distinct effects of MEK-1 inhibition on MUC2 expression in Cl.16E and HT29 cells. (a) Shows MUC2 mRNA level in Cl.16E cells (3 days postplating), untreated (c) or treated with the indicated compounds for 48 h (b) Total RNA was isolated from HT29 cells not treated (c) or treated for 8 h with the indicated agents, and analysed for MUC2 mRNA level. When PD98059 was used, cells were preincubated for 30 min with PD98059 prior to the addition of other chemicals, as described in Materials and methods. Samples shown in (a) were run on the same gel; however, cropping between the third and fourth lanes was performed to remove samples not pertinent to this work Figure 8 NaB can modulate the Cl.16E differentiation program. Total RNA from cultures of Cl. 16E growing (3 days postplating) or differentiated (15 days post plating), untreated (c) or NaB treated for the indicated time periods, was analysed by quantitative real-time PCR for intestinal alkaline phosphatase (ALPI) mRNA level, as described in Materials and methods. ALPI mRNA levels are expressed relative GAPDH mRNA. Closed and open bars indicate ALPI RNA levels in growing Cl16E (Cl16E-G) and confluent Cl16E (Cl16E-C) cells, respectively Repression of MUC2 gene by butyrate L Augenlicht et al Bradbury, 1992) . Our data suggest that MUC2 repression by NaB in HT29 cells is linked to its ability to inhibit HDAC activity, since TSA, like NaB an inhibitor of HDAC (Yoshida et al., 1990) , can also inhibit MUC2 expression in F-and TPA-induced HT29 cells. In HT29 cells TSA was as effective as butyrate. However, in contrast to NaB, TSA did not apparently affect MUC2 expression in Cl.16E cells. We demonstrated that this differential effect in the two cell lines was not linked to different mechanisms of regulation of the MUC2 gene, but to the transient inhibitory effects of TSA on HDAC, as opposed to the persistent effects of NaB. The different kinetics of inhibition also explain why there is only a partial overlap in the responses which are elicited by butyrate and TSA treatment, as demonstrated by the inability of TSA to induce CEA expression in Cl.16E cells. Indeed, utilizing comparative analysis of the profile of gene expression in colonic cells treated with TSA or butyrate, our group has recently shown that TSA regulates the expression of only a subset of the genes regulated by NaB, the immediate early genes that are altered in expression at early time of induction, and that the kinetics of induction/repression of the subset of genes common to TSA and NaB treatment is consistent with the kinetics of alteration of histone acetylation by TSA (Mariadason et al., 2000) . Furthermore, a recent report (Wu et al., 2001) demonstrated that only repeated treatment of TSA, which induced a prolonged histone hyperacetylation, could affect HT29 differentiation. In agreement with data showing the requirement for a sustained HDAC inhibition, SAHA, a stable HDAC inhibitor, was as potent as NaB in inhibiting MUC2 expression (data not shown).
Although chromatin reorganization because of histone hyperacetylation generally correlates positively with gene activation, there are examples in which histone acetylation has been associated with gene repression, as seen in pericentric heterochromatin in Drosophila (Turner et al., 1992; De Rubertis et al., 1996) and silent loci in yeast (Braunstein et al., 1996) . In addition, there is increasing evidence that acetylation can be a post-translational modification regulating the activity of many proteins, in addition to histones, including several transcription factors and/or repressors. We have recently reported that NaB and TSA elicit a complex reprogramming of gene expression in colon cancer cells which includes both up-and downregulation of many genes (Mariadason et al., 2000) . Similarly, 21 genes have been shown to be downregulated in NaBtreated HT29 cells that include oncogenes, cell cycle control proteins and transcription factors (Iacomino et al., 2001) . In this regard, it was recently shown that the activity of the TCF-4/b-catenin complex was repressed by acetylation of TCF-4 (Waltzer and Bienz, 1998) . Thus, both acetylation of histones and of specific transcription factor(s) and/or repressors(s) may mediate the inhibition of MUC2 gene expression.
Although it is well established that histone acetylation is a consequence of the activity of HDAC inhibitors, it has been reported that protein kinases and phosphatases may also play a complex role in butyrate-induced responses, and may be effectors of HDAC inhibitors (Cuisset et al., 1997 (Cuisset et al., , 1998 Espinos et al., 1999) . Our data utilizing a specific inhibitor of MEK-1 kinase activity, PD98059, which has been shown to block induction of viral promoters by NaB, show that MEK-1 is not involved in the repressive effects of NaB. In contrast, we show that PD98059 alone induced overexpression of MUC2 in Cl.16E cells, similar to the effects of this inhibitor on both MUC2 and ITF in a different cell system (Taupin and Podolsky, 1999) . Moreover, PD98059 inhibited MUC2 expression in Ftreated HT29 cells, as reported by Lee et al. (2002) , further documenting that MUC2 gene expression can be regulated by distinct mechanisms, which are activated in response to external signals or to the intrinsic pathway of cell differentiation. However, in both differentiated Cl.16E cells, and F-and TPA-induced HT29 cells, NaB is capable of repressing MUC2 expression, suggesting that a key common regulator(s) and/or chromatin reorganization are the targets of butyrate activity.
NaB as a component of an adaptive response for intestinal homeostasis
In vivo, NaB is the preferred energy source for colonocytes and thereby promotes proliferation of normal intestinal cells (Rowe and Bayless, 1992; Scheppach, 1994) . In contrast, in vitro, in human adenocarcinoma cell lines, NaB induces cell growth inhibition, accompanied by the induction of markers of differentiation and apoptosis (Heerdt et al., 1994) . This apparent paradox of NaB activity has been partially explained by hypothesizing that the activity of NaB is dependent upon its intracellular concentration and the available energy source (Hague et al., 1997; Hass et al., 1997; Singh et al., 1997) .
The repression of MUC2 by NaB, which we have documented in in vitro systems, may reflect a signaling function in the intestine that is critical for the reprogramming of the goblet cell lineage as cells migrate towards the intestinal lumen from the base of the crypt. Consistent with this hypothesis, intestinal trefoil factor (ITF), which is also secreted by goblet cells in association with mucins, is likewise inhibited by NaB treatment (Tran et al., 1998 and data not shown). In contrast, the role of NaB as modulator of the absorptive phenotype is documented by its ability to induce CEA and MUC3. In vivo, these two genes are expressed both in goblet cells and enterocytes in the upper portion of the crypt (Chang et al., 1994; Weiss et al., 1996; Ilantzis et al., 1997) ; in vitro, CEA and MUC3 can be induced by NaB (Velcich et al., 1995 and data not shown) . Indeed, the intestine may have developed specific mechanisms that respond to natural compounds present in the intestinal lumen, such as butyrate, to modulate cellular differentiation as a consequence of cell position along the crypt axis. Thus, the repressive and stimulatory effects of butyrate on the secretory and absorptive cell lineages documented in vitro may play an important role in intestinal homeostasis.
Materials and methods
Cell culture and treatment HT29 cells were maintained and treated at 70-80% confluence with F (1 mg/ml) or TPA (10 ng/ml), as previously described (Velcich and Augenlicht, 1993) . NaB and TSA were used at 5 mm and 1 mm, respectively. In experiments using PD98059, cell cultures were preincubated with 20 mm of PD98059 for 30 min prior to the addition of NaB. Actinomycin D was used at 8 mg/ml. Growing and differentiated cultures of Cl.16E cells, maintained in DMEM supplemented with 10% bovine fetal serum and glutamine, were seeded at a density of 10 6 cells/ 25 cm 2 flask and used 3 and 15 days after plating, respectively (Augeron and Laboisse, 1984) . All experiments were performed at least twice.
RNA isolation and analysis
Total RNA was isolated and analysed by Northern blot as previously described (Velcich and Augenlicht, 1993) , and results quantified using the Storm Imaging System and ImagQuant software (Molecular Dynamics, Amersham Biosciences, Piscataway, NJ, USA). Probes for the detection of MUC2, CEA, GAPDH, were described previously (Velcich and Augenlicht, 1993) . For quantitative real-time PCR analysis, cDNA isolated at the indicated time points were prepared by random priming using Superscript RT II reverse transcriptase (Invitrogen) following the manufacturer's instruction. Amplification was conducted in a 7900HT real-time PCR apparatus (Applied Biosystems, ABI, Foster City, CA, USA) using SYBR Green Core Reagent Kit (ABI) using the following primers: human intestinal alkaline phosphatase forward: 5 0 -CTCCAACATGGACATTGACG. Reverse: 5 0 -CAGTGCGGTTCCACACATAC. Reaction specificity was evaluated by the analysis of product melting curves and gel analysis. Each time course was essayed in triplicate, and GAPDH cDNA levels were used in each set of reactions as an internal control for equal amount of starting material.
Cell lysate preparation, Western blot and antibodies
For the analysis of MUC2 apoprotein, total cell extracts were prepared and analysed as previously reported (Velcich et al., 1995) . The primary antibody to detect MUC2 was M53, a monoclonal antibody generated against a bacterially expressed fusion protein containing three complete copies of the MUC2 23 amino-acid long tandem repeat (O'Boyle and Velcich, unpublished) . It was used undiluted directly from the cell culture supernatant. Detection of acetylated histone H4 was performed using cell extracts prepared as described (Mariadason et al., 2000) using antiacetylated histone H4-specific antibody (Upstate Biotechnology, Lake Placid, NY, USA; 1 : 1000) as reported (Mariadason et al., 2000) . After transfer Western blot membranes were stained with Ponceau S to control for equal sample loading and transfer.
Abbreviations F, forskolin; HDAC, histone deacetylase; ITF, intestinal trefoil factor; MEK-1, mitogen-activated protein kinase kinase-1; NaB, sodium butyrate; TSA, trichostatin A; TPA, 12-O-tetradecanoylphorbol 13-acetate.
